January Price Hikes 2.0 Methodology and Data Set
Methodology and Dataset for January Price Hikes 2.0 Report
Methodology and Dataset for January Price Hikes 2.0 Report
The report demonstrates why urgent congressional action is needed to address Big Pharma’s abusive pricing practices.
"Patients are counting on Congress and the Biden administration to deliver drug pricing reforms immediately in this new year."
Government And Taxpayers Saved The Day; Drug Corporations Did Their Job, Then Cashed In
Patients For Affordable Drugs Responds To The Industry’s $18 Million Attack Ads Aimed At Thwarting Reforms To Lower Drug Prices
The FDA’s approval of Semglee as an interchangeable biosimilar to Lantus is an important step forward on the road to real competition.
Patients For Affordable Drugs’ Analysis Highlights Need For Medicare Negotiation For All Drugs
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.